IX Biopharma News

IX Biopharma Restructures Board Committees for Efficiency

TipRanksOct 17 07:12 ET

IX Biopharma Welcomes Aging Expert to Advisory Board

TipRanksOct 14 06:13 ET

IX Biopharma Schedules Extraordinary General Meeting for Scheme Extensions

MT NewswiresSep 30 22:52 ET

Financial Statements and Related Announcement-Auditor's Comments of Accounts

SGXSep 30 10:52 ET · Announcements

IX Biopharma Advances Wafermine Out-Licensing, Starts Preclinical Trials for IXB 401

MT NewswiresSep 16 22:41 ET

New Study Demonstrates That SL-NAD+ Delivers NAD+ Into Cells

PR NewswireSep 1 21:00 ET

IX Biopharma's New Wafer Revolutionizes NAD+ Supplementation

TipRanksSep 1 20:17 ET

IX Biopharma Widens Net Loss by 12% in FY2024

Singapore Business ReviewAug 27 04:51 ET

IX Biopharma's Net Attributable Loss Widens in Fiscal H2

MT NewswiresAug 26 00:46 ET

IX Biopharma Full Year 2024 Earnings: S$0.014 Loss per Share (Vs S$0.013 Loss in FY 2023)

Yahoo FinanceAug 24 21:57 ET

Financial Statements and Related Announcement-Full Yearly Results

SGXAug 23 06:02 ET · Announcements

IX Biopharma's CBD Wafer Shows Potential in Improving Symptoms for Kidney Failure Patients; Shares Up 4%

MT NewswiresAug 12 23:15 ET

IX Biopharma's CBD Wafer Shows Promise for Kidney Failure Symptoms

TipRanksAug 12 07:17 ET

IX Biopharma Issues 115 Million Rights Shares, 57.5 Million Warrants

MT NewswiresJul 21 23:25 ET

IX Biopharma Expands Capital With New Shares and Warrants

TipRanksJul 19 06:48 ET

Singapore Shares Track Global Losses to End Week in Red; GRP Shares Climb 3%

MT NewswiresJul 19 05:39 ET

IX Biopharma Raises SG$3.3 Million From Rights Cum Warrants Issue

MT NewswiresJul 18 23:03 ET

IX Biopharma Ltd Faces Rights Issue Shortfall

TipRanksJul 15 06:20 ET

IX Biopharma's Sublingual NAD+ Wafers Show Promising Results in Human Trial

MT NewswiresJul 9 22:40 ET

IX Biopharma's Trial Boosts NAD+ and Wellness

TipRanksJul 9 07:18 ET